Investing Profile

Jayadev Shastri(11)

CEOVCFounderAdvisor
Managing Director
Photo of Jayadev Shastri, Managing Director

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture

2 Investors

Connected to Gigi Levy-Weiss (NFX), Omri Amirav Drory (NFX).

Managing Director
$25K - $40K
$35K
At Jays MedLabs we have 1000 novel drug molecules Alzheimer's, Cancer, Stroke are our core focus areas. 100 drugs have been repurposed to target other diseases, Mefloquine has been repurposed to target Alzheimer's. AI wearable is the next project wearable smart patches/implants for muscle injury and spinal repair. In the pipeline, 4 Protein conjugate drugs for stroke and breast cancer. Clinical trials will commence in 2024 end.
Managing Director JaysMedLabs2019 - Present
Managing Director _______________________________________________________________________2019 - Present
Managing Director JDLabs_2009 - 2020
School Of Open Learning Doctor of Philosophy (Ph.D.) Reduction of Side effects of Cancer Medicines
School Of Open Learning Doctor of Philosophy - PhD Computational Chemistry
Sri Ramachandra Medical College & Research Institute, Porur B. Pharm (B.Tech. Pharmacy) (P.C.I. and A.I.C.T.E Approved
Russian Centre Russian Language Diploma Russian Studies
DAV Public School Intermediate Intermediate
Holy Angels School SSLC; C.S.E High School